{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:39:28Z","timestamp":1783636768164,"version":"3.55.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"Supplement_7","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mathematical modeling can be used to project the impact of mass vaccination on cholera transmission. Here, we discuss 2 examples for which indirect protection from mass vaccination needs to be considered. In the first, we show that nonvaccinees can be protected by mass vaccination campaigns. This additional benefit of indirect protection improves the cost-effectiveness of mass vaccination. In the second, we model the use of mass vaccination to eliminate cholera. In this case, a high population level of immunity, including contributions from infection and vaccination, is required to reach the \u201cherd immunity\u201d threshold needed to stop transmission and achieve elimination.<\/jats:p>","DOI":"10.1093\/infdis\/jiab472","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T19:10:36Z","timestamp":1631733036000},"page":"S738-S741","source":"Crossref","is-referenced-by-count":4,"title":["Mathematical Modeling of Endemic Cholera Transmission"],"prefix":"10.1093","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8253-6321","authenticated-orcid":false,"given":"Dennis L","family":"Chao","sequence":"first","affiliation":[{"name":"Institute for Disease Modeling; Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"2021122015213070900_CIT0001","first-page":"477","article-title":"Cholera vaccines: WHO position paper\u2014August 2017.","volume":"92","author":"World Health Organization.","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"2021122015213070900_CIT0002","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2021122015213070900_CIT0003","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12879-018-2981-4","article-title":"Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial.","volume":"18","author":"Fong","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2021122015213070900_CIT0004","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1371\/journal.pntd.0000173","article-title":"The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa.","volume":"2","author":"Deen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"2021122015213070900_CIT0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4269\/ajtmh.14-0159","article-title":"Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator.","volume":"91","author":"Troeger","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"2021122015213070900_CIT0006","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"key":"2021122015213070900_CIT0007","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1017\/S0950268815000692","article-title":"The contribution of neighbours to an individual\u2019s risk of typhoid outcome.","volume":"143","author":"Chao","year":"2015","journal-title":"Epidemiol Infect"},{"key":"2021122015213070900_CIT0008","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"2021122015213070900_CIT0009","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","article-title":"Controlling endemic cholera with oral vaccines.","volume":"4","author":"Longini","year":"2007","journal-title":"PLoS Med"},{"key":"2021122015213070900_CIT0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/cir007","article-title":"\u201cHerd immunity\u201d: a rough guide.","volume":"52","author":"Fine","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021122015213070900_CIT0011","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21645515.2017.1392422","article-title":"Global economic evaluation of oral cholera vaccine: a systematic review.","volume":"14","author":"Teoh","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2021122015213070900_CIT0012","doi-asserted-by":"crossref","first-page":"e3343","DOI":"10.1371\/journal.pntd.0003343","article-title":"Comparative effectiveness of different strategies of oral cholera vaccination in Bangladesh: a modeling study.","volume":"8","author":"Dimitrov","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2021122015213070900_CIT0013","doi-asserted-by":"crossref","first-page":"e0006652","DOI":"10.1371\/journal.pntd.0006652","article-title":"The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: a disease modeling and economic analysis.","volume":"12","author":"Khan","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2021122015213070900_CIT0014","doi-asserted-by":"crossref","first-page":"L19401","DOI":"10.1029\/2009GL039312","article-title":"Dual peak cholera transmission in Bengal Delta: a hydroclimatological explanation.","volume":"36","author":"Akanda","year":"2009","journal-title":"Geophys Res Lett"},{"key":"2021122015213070900_CIT0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1204927","article-title":"Cholera surveillance during the Haiti epidemic\u2013the first 2 years.","volume":"368","author":"Barzilay","year":"2013","journal-title":"N Engl J Med"},{"key":"2021122015213070900_CIT0016","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/aem.48.2.420-424.1984","article-title":"Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar 01 associated with live copepods in laboratory microcosms.","volume":"48","author":"Huq","year":"1984","journal-title":"Appl Environ Microbiol"},{"key":"2021122015213070900_CIT0017","doi-asserted-by":"crossref","first-page":"e1081","DOI":"10.1016\/S2214-109X(20)30310-7","article-title":"Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.","volume":"8","author":"Lee","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2021122015213070900_CIT0018","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1073\/pnas.1102149108","article-title":"Vaccination strategies for epidemic cholera in Haiti with implications for the developing world.","volume":"108","author":"Chao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021122015213070900_CIT0019","article-title":"The dry season in Haiti: a window of opportunity to eliminate cholera.","author":"Rebaudet","journal-title":"PLoS Curr"},{"key":"2021122015213070900_CIT0020","author":"Pan American Health Organization.","year":"2020"},{"key":"2021122015213070900_CIT0021","first-page":"195","article-title":"Modeling cholera outbreaks.","volume-title":"Cholera outbreaks: current topics in microbiology and immunology","author":"Chao","year":"2014"},{"key":"2021122015213070900_CIT0022","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2307\/4592985","article-title":"Epidemiologic basis for eradication of measles in 1967.","volume":"82","author":"Sencer","year":"1967","journal-title":"Public Health Rep"},{"key":"2021122015213070900_CIT0023","first-page":"S17","article-title":"Evolution of measles elimination strategies in the United States.","volume":"189(suppl 1)","author":"Hinman","year":"2004","journal-title":"J Infect Dis"},{"key":"2021122015213070900_CIT0024","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/aje\/kwp237","article-title":"Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.","volume":"170","author":"Basta","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2021122015213070900_CIT0025","doi-asserted-by":"crossref","first-page":"e1001527","DOI":"10.1371\/journal.pmed.1001527","article-title":"Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.","volume":"10","author":"Baguelin","year":"2013","journal-title":"PLoS Med"},{"key":"2021122015213070900_CIT0026","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12916-015-0452-y","article-title":"Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.","volume":"13","author":"Baguelin","year":"2015","journal-title":"BMC Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab472\/40427018\/jiab472.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_7\/S738\/41826193\/jiab472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_7\/S738\/41826193\/jiab472.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T15:23:21Z","timestamp":1640013801000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/Supplement_7\/S738\/6373915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":26,"journal-issue":{"issue":"Supplement_7","published-online":{"date-parts":[[2021,9,22]]},"published-print":{"date-parts":[[2021,12,20]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab472","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,15]]},"published":{"date-parts":[[2021,9,22]]}}}